Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/1999

01-06-1999 | Review

The challenge of early synovitis: multiple pathways to a common clinical syndrome

Author: Hani El-Gabalawy

Published in: Arthritis Research & Therapy | Issue 1/1999

Login to get access

Excerpt

Synovial inflammation involving one or more joints is the presenting feature, and often the predominant clinical manifestation of a spectrum of pathologic states, many of which continue to be incompletely understood. The outcome of early synovitis can range from rapid and complete resolution to a persistent inflammatory process associated with irreversible articular damage and progressive functional decline. …
Literature
1.
Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324.CrossRef
2.
Dougados M, van der Linden S, Juhlin R, et al: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991, 34: 1218-1227.CrossRef
3.
El-Gabalawy HS, Goldbach-Mansky R, Smith D, et al: Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum. 1999, 42: 1696-1705.CrossRef
4.
Hulsemann JL, Zeidler H: Undifferentiated arthritis in an early synovitis out-patient clinic. Clin Exp Rheumatol. 1995, 13: 37-43.
5.
Harrison BJ, Symmons DM, Brennan P, et al: Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. J Rheumatol . 1996, 23: 1326-1331.
6.
Wolfe F, Ross K, Hawley DJ, Roberts FK, Cathey MA: The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol. 1993, 20: 2005-2009.
7.
Hulsemann JL, Zeidler H: Diagnostic evaluation of classification criteria for rheumatoid arthritis and reactive arthritis in an early synovitis outpatient clinic. Ann Rheum Dis. 1999, 58: 278-280.PubMedCentralCrossRef
8.
Wollenhaupt J, Zeidler H: Undifferentiated arthritis and reactive arthritis. Curr Opin Rheumatol. 1998, 10: 306-313.CrossRef
9.
Foley-Nolan D, Stack JP, Ryan M, et al: Magnetic resonance imaging in the assessment of rheumatoid arthritis: a comparison with plain film radiographs. Br J Rheumatol. 1991, 30: 101-106.CrossRef
10.
Forslind K, Larsson EM, Johansson A, Svensson B: Detection of joint pathology by magnetic resonance imaging in patients with early rheumatoid arthritis. Br J Rheumatol. 1997, 36: 683-638.CrossRef
11.
McQueen FM, Stewart N, Crabbe J, et al: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis. 1998, 57: 350-356.PubMedCentralCrossRef
12.
Jorgensen C, Cyteval C, Anaya JM, Baron MP, Lamarque JL, Sany J: Sensitivity of magnetic resonance imaging of the wrist in very early rheumatoid arthritis. Clin Exp Rheumatol. 1993, 11: 163-168.
13.
Jevtic V, Watt I, Rozman B, et al: Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patients. Clin Exp Rheumatol. 1997, 15: 151-156.
14.
Oliver C, Speake S, Watt I, Dieppe P, Ratcliffe G: Advantages of an increased dose of MRI contrast agent for enhancing inflammatory synovium. Clin Radiol. 1996, 51: 487-493.CrossRef
15.
Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P, Volck B, Jensen CH, Lorenzen I: Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: comparison with the macroscopic and microscopic appearance of the synovium. Arthritis Rheum. 1997, 40: 1856-1867.CrossRef
16.
Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P, Volck B, Sonne-Holm S, Lorenzen I: Quantification of synovistis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging. 1998, 16: 743-754.CrossRef
17.
Ostergaard M, Hansen M, Stoltenberg M, et al: Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42: 918-929.CrossRef
18.
Jevtic V, Watt I, Rozman B, et al: Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritis. Br J Rheumatol. 1996, 35 (suppl 3): 26-30.CrossRef
19.
Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O: Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol. 1995, 24: 351-355.CrossRef
20.
McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Emery P: Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum. 1998, 41: 694-700.CrossRef
21.
McGonagle D, Gibbon W, Emery P: Classification of inflammatory arthritis by enthesitis. Lancet. 1998, 352: 1137-1140.CrossRef
22.
Tak PP, Smeets TJ, Daha MR, et al: Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum. 1997, 40: 217-225.CrossRef
23.
Tak PP, Smeets TJM, Boyle DL, et al: p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum. 1999, 42: 948-953.CrossRef
24.
Thurkow EW, VanDerHeijden IM, Breedveld FC, et al: Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia induced arthritis and osteoarthritis. J Pathol. 1997, 181: 444-450. 10.1002/(SICI)1096-9896(199704)181:4<444::AID-PATH778>3.0.CO;2-O.CrossRef
25.
Smeets TJM, Dolhain RJEM, Breedveld FC, Tak PP: Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J Pathol. 1998, 186: 75-81. 10.1002/(SICI)1096-9896(199809)186:1<75::AID-PATH142>3.0.CO;2-B.CrossRef
26.
Mulherin D, Fitzgerald O, Bresnihan B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996, 39: 115-124.CrossRef
27.
Bresnihan B: Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol. 1999, 26: 717-719.
28.
Kraan MC, Versendaal H, Jonker M, et al: Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum . 1998, 41: 1481-1488.CrossRef
29.
Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR: Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol. 1998, 152: 943-951.PubMedCentral
30.
Nanagara R, Duray PH, Schumacher HR: Ultrastructural demonstration of spirochetal antigens in synovial fluid and synovial membrane in chronic Lyme disease: possible factors contributing to persistence of organisms. Hum Pathology. 1996, 27: 1025-1034.CrossRef
31.
van der Heijden IM, Wilbrink B, Rijpkema SGT, et al: Detection of Borrelia burgdorferi sensu stricto by reverse line blot in the joints of Dutch patients with lyme arthritis. Arthritis Rheum. 1999, 42: 1473-1480.CrossRef
32.
priem S, Burmester GR, Kamradt T, Wolbart K, Rittig MG, Krause A: Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy. Ann Rheum Dis. 1998, 57: 118-121.PubMedCentralCrossRef
33.
Jaulhac B, CharyValckenaere I, Sibilia J, et al: Detection of Borrelia burgdorferi by DNA amplification in synovial tissue samples from patients with Lyme arthritis. Arthritis Rheum. 1996, 39: 736-745.CrossRef
34.
Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC: Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. New Engl J Med. 1994, 330: 229-234.CrossRef
35.
Steere AC, Duray PH, Butcher EC: Spirochetal antigens and lymphoid-cell surface markers in Lyme synovitis: comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 1988, 31: 487-495.CrossRef
36.
Gross DM, Forsthuber T, Tary-Lehmann M, et al: Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 1998, 281: 703-706. 10.1126/science.281.5377.703.CrossRef
37.
Schumacher HR, Arayssi T, Crane M, et al: Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects. Arthritis Rheum . 1999, 42: 1281-1284.CrossRef
38.
Goldbach-Mansky R, Hudson A, Gerard H, et al: Does the presence of C-trachomatis in synovial tissue correlate with immune serology and outcome in recent onset synovitis?. Arthritis Rheum. 1998, 41: S148-S148.
39.
Kotake S, Schumacher HR, Yarboro CH, et al: In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc Assoc Am Physicians. 1997, 109: 286-301.
40.
Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A. 1994, 30: 8562-8566.CrossRef
41.
Kotake S, Schumacher HR, Arayssi TK, et al: Gamma interferon and interleukin-10 gene expression in synovialtissues from patients with early stages of Chlamydia associated arthritis and undifferentiated oligoarthritis and from healthy volunteers. Infect Immun. 1999, 67: 2682-2686.PubMedCentral
42.
Kotake S, Schumacher HR, Yarboro CH, et al: In vivo, gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc Assoc Am Physicians . 1997, 109: 286-301.
43.
Gerard HC, Branigan PJ, Schumacher HR, Hudson AP: SynovialChlamydia trachomatis in patients with reactive arthritis Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol. 1998, 25: 734-742.
44.
Nanagara R, Li F, Beutler A, Hudson A, Schumacher HRJ: Alteration of Chlamydia trachom atis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum. 1995, 38: 1410-417.CrossRef
45.
Takahashi Y, Murai C, Shibata S, et al: Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA. 1998, 95: 8227-8232.PubMedCentralCrossRef
46.
Saal JG, Krimmel M, STEIDLE M, et al: Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum. 1999, 42: 1485-1496.CrossRef
47.
Menard HA, El Amine M, Despres N: Rheumatoid arthritis associated autoimmune systems. J Rheumatol. 1998, 25: 835-837.
48.
Schellekens GA, de Jong BAW, Van den Hoogen FHJ, Van de Putte LBA, Van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-281.PubMedCentralCrossRef
49.
Despres N, Boire G, Lopezlongo FJ, Menard HA: The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol. 1994, 21: 1027-1033.
50.
Despres N, Talbot G, Plouffe B, Boire G, Menard HA: Detection and expression of a cDNA clone that encodes a polypeptide containing 2 inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest. 1995, 95: 1891-1896.PubMedCentralCrossRef
51.
Ligier S, Fortin PR, Newkirk MM: A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE. Br J Rheumatol. 1998, 37: 1307-1314.CrossRef
52.
Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G: Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Invest. 1997, 100: 127-135.PubMedCentralCrossRef
53.
Terato K, DeArmey DA, Ye XJ, Griffiths MM, Cremer MA: The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: possible cross-reaction of antibodies to dietary collagens with autologous type II collagen. Clin Immunol Immunopathol. 1996, 79: 142-154. 10.1006/clin.1996.0061.CrossRef
54.
Goldbach-Mansky R, Hoxworth J, Lee J, et al: RA associated autoantibodies define subsets of patients with early synovitis. Arthritis Rheum. 1999, 42 (suppl): S128-
55.
Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis: an approach to understanding the molecular-genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987, 30: 1205-1213.CrossRef
56.
Weyand CM, Hicok KC, Conn DL, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med. 1992, 117: 801-806.CrossRef
57.
Nabozny GH, Baisch JM, Cheng S, et al: HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med. 1996, 183: 27-37.CrossRef
58.
Zanelli E, Gonzalez-Gay MA, David CS: Could HLA-DRB1 be the protective locus in rheumatoid arthritis?. Immunol Today. 1995, 16: 274-278.CrossRef
59.
van der Horst-Bruinsma IE, Visser H, Hazes JMW, et al: HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol. 1999, 60: 152-158.CrossRef
60.
De Vries N, van Elderen C, Tijssen H, van Riel PLCM, Van de Putte LBA: No support for HLA-DQ encoded susceptibility in rheumatoid arthritis. Arthritis Rheum. 1999, 42: 1621-1627.CrossRef
61.
Ilonen J, Hakala M, Reijonen H, Tiilikainen A: B27-bearing HLA haplotypes in rheumatoid arthritis: characterization in Finnish patients. Hum Immunol. 1991, 30: 7-10.CrossRef
62.
Paimela L, Leirisalorepo M, Helve T, Koskimies S: The prognostic value of HLA-DR4 and HLA-B27 antigens in early rheumatoid arthritis. Scand J Rheumatol. 1993, 22: 220-224.CrossRef
63.
Yang HT, Jirholt J, Svensson L, et al: Identification of genes controlling collagen-induced arthritis in mice: striking homology with susceptibility loci previously identified in the rat. J Immunol. 1999, 163: 2916-2921.
64.
Vingsbo-Lundberg C, Nordquist N, Olofsson P, et al: Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nature Genet. 1998, 20: 401-404.CrossRef
65.
Wilkinson NZ, Kingsley GH, Jones HW, Sieper J, Braun J, Ward ME: The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology. 1999, 38: 260-266. 10.1093/rheumatology/38.3.260.CrossRef
66.
Wilbrink B, van der Heijden IM, Schouls LM, et al: Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum . 1998, 41: 535-543.CrossRef
Metadata
Title
The challenge of early synovitis: multiple pathways to a common clinical syndrome
Author
Hani El-Gabalawy
Publication date
01-06-1999
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/1999
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar8

Other articles of this Issue 1/1999

Arthritis Research & Therapy 1/1999 Go to the issue

Paper Report

Functional heterogeneity of osteoclasts

Review

Antigen-specific cytometry

Review

Genetics of rheumatoid arthritis: confronting complexity

Commentary

Current perspectives on synovitis

Review

Lessons learned from gene transfer approaches

Commentary

Gene therapy in rheumatoid arthritis: how to target joint destruction?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits